Drug Search Results

Xipamide

Alternative Names: xipamide, aquaphor
Latest Update: 2024-10-04
Latest Update Note: News Article

Product Description

Mechanisms of Action: Sodium Potassium ATPase Agonist

Novel Mechanism: Yes

Modality: Small Molecule

Route of Administration: Topical

FDA Designation: None *

Approval Status: Not Approved

Approved Indications: None

Known Adverse Events: None

Company: None
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Xipamide

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Trial	Phase	Trial Status	Disease	Primary Completion Date	Probability of Success

Recent News Events

Date	Type	Title
10/04/2024	News Article	Top Companies, Marketers, CEOs, Products, and Initiatives Were Celebrated During Trailblazer Gala on October 1st
09/12/2024	News Article	Eucerin Launches NEW Eczema Relief Hydrogel With Jason Bolden
09/10/2024	News Article	Aquaphor Launches Its First-Ever Naturally Inspired Lip Collection
08/08/2024	News Article	PM360 Announces 2024 Trailblazer Award Finalists

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions